01.01.2024 – 31.12.2028
The consortium brings together an outstanding team with excellent scientific, clinical and organisational expertise to deliver this study, interpret the findings appropriately and disseminate them to provide international impact on improving systems of care for patients with advanced COPD. The consortium builds upon a number of previous international collaborations and national studies, by leading scientists in the fields of respiratory medicine, palliative care and health services research. The consortium reflects the expertise required to run a successful trial in what is often regarded as a challenging area.
Project coordinator (WP1) and work package leader of Stepped wedge RCT effectiveness trial (WP5) and scientific co-leadership (WP7, WP8 and WP9)
Work package leader of the adaptation, standardisation of ICLEAR into ICLEAR-EU and its
feasibility testing (WP2)
Work package leader of the adaptation, standardisation of Mixed methods process and implementation evaluation (WP8) and scientific co-leadership (WP3)
Work package leader of the adaptation, standardisation Data analyses incl. Subgroup and country comparative analyses (WP7) and scientific co-leadership (WP5, WP2)
Scientific co-lead of training development and implementation guidance (WP3)
Work package leader of development of protocol, ethics, questionnaires & piloting of data collection (WP4) and scientific co-leadership (WP5)
Scientific co-lead of development of protocol, ethics, questionnaires & piloting of data collection (WP4)
Work package leader of training development and implementation guidance (WP3)
Work package leader of Stakeholder engagement, communication, dissemination and exploitation (WP9)
Co-lead of stakeholder engagement, communication,
dissemination and exploitation (WP9)
Co-lead of stakeholder engagement, communication,
dissemination and exploitation (WP9)
Co-lead of stakeholder engagement, communication,
dissemination and exploitation (WP9)
The information you provide will only be used for newsletter campaigns by EU PAL-COPD. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s terms of use. You can unsubscribe at any time by clicking the link in the footer of our emails. Read our privacy policy to learn how your data is used.
EU PAL-COPD is funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them [grant number 101136621]. This project is also supported by the UK Research and Innovation (UKRI) [grant numbers 10109731 and 10109782], the Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund [grant number 2020-2.1.1-ED-2023-00260], and the Swiss State Secretariat for Education, Research and Innovation (SERI).
© 2024 accelopment Schweiz AG · info@accelopment.com · ISO 9001 certified · Read our Privacy Policy and Cookie Policy
Stay informed about latest EU PAL-COPD results and milestones.
